Ventavis Approval History
- FDA approved: Yes (First approved December 29th, 2004)
- Brand name: Ventavis
- Generic name: iloprost
- Company: CoTherix, Inc.
- Treatment for: Pulmonary Arterial Hypertension
Ventavis (iloprost) inhalation solution is synthetic analogue of prostacyclin PGIB2B indicated for the treatment of pulmonary arterial hypertension.
FDA Approval History for Ventavis
|Dec 29, 2004||Ventavis CoTherix, Inc. - Treatment for Pulmonary Arterial Hypertension|
|Sep 8, 2004||CoTherix, Inc. Announces Priority Review Designation by the FDA for Ventavis NDA|
|Jul 1, 2004||CoTherix, Inc. Announces Filing of Ventavis NDA|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.